Philip Clay

Philip is Director and Principal Toxicologist with Chorley Consulting. He is a UK and European registered toxicologist and specialises in product safety assessment with over 30 years experience in toxicology and safety assessment. He is a BSI committee member on CH/194  (Biological evaluation of medical devices) and Principal Expert for WG6 (Mutagenicity, carcinogenicity and reproductive toxicity). He established his reputation as a genetic toxicologist working within the agrochemical, chemical and pharmaceutical industries. He has contributed to many expert panels, helping to shape the testing guidelines and strategies in place today. More recently, this experience and depth of understanding has been applied to designing safety assessment programmes for medical devices for a wide range of device manufacturers. He has published and presented widely in the field of toxicology throughout his career.

  • Next: 11-12 Mar 2024 Classroom
  • Also: 16-17 Sep 2024 Classroom

Biological Evaluation of Medical Devices


Key guidance on how to use the ISO 10993 series of standards and successfully apply a risk management approach to the biological evaluation of medical devices. *Includes:* Interactive workshops and discussion sessions

  • 12 CPD hours Focused
  • Presented by Philip Clay